idTarget: A web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach

Nucleic Acids Research

Volumn 40, Issue W1, 2012, Pages

  Wang, Jui Chih ^a   Chu, Pei Ying ^b   Chen, Chung Ming ^a   Lin, Jung Hsin ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b RESEARCH CENTER FOR APPLIED SCIENCES   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

6 BROMO INDIRUBIN 3' OXIME; DARUNAVIR; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; INDIRUBIN; N (4 AMINOBIPHENYL 3 YL) BENZAMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG SCREENING; DRUG STRUCTURE; INFORMATION PROCESSING; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATA BANK; PROTEIN STRUCTURE; PROTEIN TARGETING; REGRESSION ANALYSIS; WEB BROWSER;

DRUG DESIGN; HISTONE DEACETYLASE INHIBITORS; HIV PROTEASE INHIBITORS; INDOLES; INTERNET; LIGANDS; MODELS, MOLECULAR; OXIMES; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; PROTEINS; SOFTWARE; SULFONAMIDES;

EID: 84864453939     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks496     Document Type: Article

References (38)

1. Lin, Y.C., Lin, J.H., Chou, C.W., Chang, Y.F., Yeh, S.H. and Chen, C.C. (2008) Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res., 68, 2375-2383.
2. Shoichet, B.K. (2004) Virtual screening of chemical libraries. Nature, 432, 862-865.
3. Chen, Y.Z. and Zhi, D.G. (2001) Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins-Struct. Funct. Genet., 43, 217-226.
4. Keiser, M.J., Setola, V., Irwin, J.J., Laggner, C., Abbas, A.I., Hufeisen, S.J., Jensen, N.H., Kuijer, M.B., Matos, R.C., Tran, T.B. et al. (2009) Predicting new molecular targets for known drugs. Nature, 462, 175-U148.
5. Yang, L., Luo, H., Chen, J., Xing, Q.H. and He, L. (2009) SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome. Nucleic Acids Res., 37, W406-W412.
6. Wale, N. and Karypis, G. (2009) Target fishing for chemical compounds using target-ligand activity data and ranking based methods. J. Chem. Inf. Model., 49, 2190-2201.
7. Kellenberger, E., Foata, N. and Rognan, D. (2008) Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems. J. Chem. Inf. Model., 48, 1014-1025.
8. Xie, L. and Bourne, P.E. (2011) Structure-based systems biology for analyzing off-target binding. Curr. Opin. Struct. Biol., 21, 189-199.
9. Wang, J.C., Lin, J.H., Chen, C.M., Perryman, A.L. and Olson, A.J. (2011) Robust scoring functions for protein-ligand interactions with quantum chemical charge models. J. Chem. Inf. Model., 51, 2528-2537.
10. Huey, R., Morris, G.M., Olson, A.J. and Goodsell, D.S. (2007) A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem., 28, 1145-1152.
11. Bayly, C.I., Cieplak, P., Cornell, W.D. and Kollman, P.A. (1993) A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges-the Resp model. J. Phys. Chem., 97, 10269-10280.
12. Jakalian, A., Bush, B.L., Jack, D.B. and Bayly, C.I. (2000) Fast, efficient generation of high-quality atomic Charges. AM1-BCC model: I. Method. J. Comput. Chem., 21, 132-146.
13. Rousseeuw, P.J. and Van Driessen, K. (2006) Computing LTS regression for large data sets. Data Min. Knowledge Discov., 12, 29-45.
14. Cheng, T.J., Li, X., Li, Y., Liu, Z.H. and Wang, R.X. (2009) Comparative assessment of scoring functions on a diverse test set. J. Chem. Inf. Model., 49, 1079-1093.
15. Wang, R.X., Lu, Y.P. and Wang, S.M. (2003) Comparative evaluation of 11 scoring functions for molecular docking. J. Med. Chem, 46, 2287-2303.
16. Chang, D.T.H., Oyang, Y.J. and Lin, J.H. (2005) MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm. Nucleic Acids Res., 33, W233-W238.
17. Chang, D.T.H., Lin, J.H., Hsieh, C.H. and Oyang, Y.J. (2010) On the design of optimization algorithms for prediction of molecular interactions. Int. J. Artif. Intelligence Tools, 19, 267-280.
18. Vaque, M., Arola, A., Aliagas, C. and Pujadas, G. (2006) BDT: an easy-to-use front-end application for automation of massive docking tasks and complex docking strategies with AutoDock. Bioinformatics, 22, 1803-1804.
19. Cheng, A.C., Coleman, R.G., Smyth, K.T., Cao, Q., Soulard, P., Caffrey, D.R., Salzberg, A.C. and Huang, E.S. (2007) Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol., 25, 71-75.
20. Kellenberger, E., Muller, P., Schalon, C., Bret, G., Foata, N. and Rognan, D. (2006) sc-PDB: an annotated database of druggable binding sites from the protein data bank. J. Chem. Inf. Model., 46, 717-727.
21. Meslamani, J., Rognan, D. and Kellenberger, E. (2011) sc-PDB: a database for identifying variations and multiplicity of 'druggable' binding sites in proteins. Bioinformatics, 27, 1324-1326.
22. Huang, Y., Niu, B.F., Gao, Y., Fu, L.M. and Li, W.Z. (2010) CD-HIT Suite: a web server for clustering and comparing biological sequences. Bioinformatics, 26, 680-682.
23. Shulman-Peleg, A., Nussinov, R. and Wolfson, H.J. (2005) SiteEngines: recognition and comparison of binding sites and protein-protein interfaces. Nucleic Acids Res., 33, W337-W341.
24. Shindyalov, I.N. and Bourne, P.E. (1998) Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng., 11, 739-747.
25. O'Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T. and Hutchison, G.R. (2011) Open Babel: an open chemical toolbox. J. Cheminform, 3, 33.
26. Surleraux, D.L.N.G., Tahri, A., Verschueren, W.G., Pille, G.M.E., de Kock, H.A., Jonckers, T.H.M., Peeters, A., De Meyer, S., Azijn, H., Pauwels, R. et al. (2005) Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor. J. Med. Chem, 48, 1813-1822.
27. Zahler, S., Tietze, S., Totzke, F., Kubbutat, M., Meijer, L., Vollmar, A.M. and Apostolakis, J. (2007) Inverse in silico screening for identification of kinase inhibitor targets. Chem. Biol., 14, 1207-1214.
28. Liu, F.L., Kovalevsky, A.Y., Tie, Y.F., Ghosh, A.K., Harrison, R.W. and Weber, I.T. (2008) Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir. J. Mol. Biol., 381, 102-115.
29. Kovalevsky, A.Y., Tie, Y.F., Liu, F.L., Boross, P.I., Wang, Y.F., Leshchenko, S., Ghosh, A.K., Harrison, R.W. and Weber, I.T. (2006) Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M. J. Med. Chem, 49, 1379-1387.
30. Tie, Y.F., Boross, P.I., Wang, Y.F., Gaddis, L., Hussain, A.K., Leshchenko, S., Ghoshl, A.K., Louis, J.M., Harrison, R.W. and Weber, I.T. (2004) High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains. J. Mol. Biol., 338, 341-352.
31. Kosmopoulou, M.N., Leonidas, D.D., Chrysina, E.D., Bischler, N., Eisenbrand, G., Sakarellos, C.E., Pauptit, R. and Oikonomakos, N.G. (2004) Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b-comparison with ligand binding to pCDK2-cyclin A complex. Eur J. Biochem., 271, 2280-2290.
32. Sing, T., Sander, O., Beerenwinkel, N. and Lengauer, T. (2005) ROCR: visualizing classifier performance in R. Bioinformatics, 21, 3940-3941.
33. Bressi, J.C., Jennings, A.J., Skene, R., Wu, Y.Q., Melkus, R., De Jong, R., O'Connell, S., Grimshaw, C.E., Navre, M. and Gangloff, A.R. (2010) Exploration of the HDAC2 foot pocket: synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorg. Med. Chem. Lett, 20, 3142-3145.
34. Gruber, V.A., Rainey, P.M., Moody, D.E., Morse, G.D., Ma, Q., Prathikanti, S., Pade, P.A., Alvanzo, A.A.H. and McCance-Katz, E.F. (2012) Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin. Infect. Dis., 54, 414-423.
35. Brown, K.C., Paul, S. and Kashuba, A.D.M. (2009) Drug interactions with new and investigational antiretrovirals. Clin. Pharmacokinet., 48, 211-241.
36. van de Waterbeemd, H. and Gifford, E. (2003) ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov., 2, 192-204.
37. Cruciani, G., Carosati, E., De Boeck, B., Ethirajulu, K., Mackie, C., Howe, T. and Vianello, R. (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J. Med. Chem, 48, 6970-6979.
38. Aller, S.G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R.P., Harrell, P.M., Trinh, Y.T., Zhang, Q.H., Urbatsch, I.L. et al. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science, 323, 1718-1722